Americans Spent $158 Billion on Their Pets. The Companies That Sell Them Everything Are Trading Like a Recession

The marketing deck says pets are family. Industry executives repeat it on earnings calls as if it were a law of physics. Hallmark built a greeting-card category around it. The 2024 numbers from the American Pet Products Association back it up: U.S. households spent $158 billion on dogs, cats, birds, fish, and reptiles in 2024, and APPA now projects $165 billion for 2026. Pet food and treats alone are forecast to clear $69.7 billion. Veterinary care will clear $42.4 billion.

That is the story investors have been told since 2020: pets are a non-cyclical, discretionary-but-sticky, millennial-and-Gen-Z-fueled growth category that keeps compounding regardless of the macro cycle. It is why Chewy's IPO priced at the top of the range in 2019. It is why Trupanion was valued like a software company. It is why Idexx Laboratories traded at a biotech multiple for most of the last decade.

That story broke this year, and nobody rang a bell.

As of the October 30 close, Chewy ($CHWY) is down 36.4% year-to-date and sitting near its 52-week low of $17.40. Idexx ($IDXX), the dominant veterinary diagnostics franchise, is down 17.7% YTD and trading closer to $551 than its $770 high. Trupanion ($TRUP), the pet insurance pure-play, is down 24.7% over the trailing year and trades at $30 against a $47 high. PetMed Express ($PETS), the discount pharmacy, is at $1.19 — a penny stock in all but name. Elanco ($ELAN), the animal-health pharma spin-out from Eli Lilly, is the only one of the five that is up over the trailing year, and barely — about 4%.

The S&P 500 is up 10.8% over the same twelve months.

That is a very specific pattern. It is not a rate-sensitivity story — if it were, pet insurance (long-duration cash flows) and pet food (consumer staple) would move in opposite directions, and they haven't. It is not a sector-wide consumer discretionary rout — Costco, Walmart, and TJX are near all-time highs. It is a pet-economy specific divergence, and the people inside the industry know exactly why it is happening. Wall Street has mostly chosen not to say it out loud.

The Headline Everyone Repeats

The APPA number is real, and it keeps going up. $136.8 billion in 2022. $147 billion in 2023. $158 billion in 2024. $165 billion projected for 2026. In nominal dollars, this looks like a steady, boring compounder. Industry conferences treat the chart as destiny.

But a chart that only tracks nominal spend hides three things that matter to equity holders:

1. How much of the growth is price, not volume.
2. Who captures the spend inside the value chain.
3. Whether the marginal pet owner is the same consumer who drove the 2020–2022 boom.

Peel the APPA table apart and the composition is doing something investors in the big names should be paying attention to. Vet care is projected to grow faster than food. "Other services" — which APPA defines as boarding, grooming, insurance, training, pet sitting, pet walking, and everything outside veterinary care — barely moves. Supplies, the historical core of pet-store retail, is nearly flat.

In other words: the only two categories still growing meaningfully are the ones with the most inelastic demand (an animal that is actually sick) and the one with the most pricing power (prescription food and specialty diets). The categories that correlate with discretionary pet ownership — toys, beds, grooming, boarding, treats — are the ones softening. The industry total keeps climbing because the dogs that already exist are getting more expensive to keep alive, not because Americans are acquiring more dogs.

That is the story the stocks are pricing. The headline misses it.

A free membership gets you access to every free article at AlphaBriefing.com: Join AlphaBriefing